Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. 1979

T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive

Related Publications

T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
January 1986, Clinical neuropharmacology,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
September 1987, Epilepsy research,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
May 1969, Current therapeutic research, clinical and experimental,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
January 1985, Der Nervenarzt,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
October 1988, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
January 1964, The Psychiatric quarterly,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
March 1989, British journal of clinical pharmacology,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
June 1977, Neurology,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
August 1967, Current therapeutic research, clinical and experimental,
T Okuma, and K Inanaga, and S Otsuki, and K Sarai, and R Takahashi, and H Hazama, and A Mori, and M Watanabe
October 1983, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!